ARTICANZ - Beta (ver 0.9)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/FLT3

Search results

target/FLT3
9 trial(s) found.
NCT06578247
NCT06366789
NCT06325748
NCT04581512
NCT03409081
ACTRN12624000082505
ACTRN12620000849998
OLD TRIAL
ACTRN12619001655134
ACTRN12621000991819
Not Applicable
Filters
OLD TRIAL
FLT3
100%
KIT
44%
PDGFR
33%
AXL
22%
BCL2
22%
CRAF
22%
RAF
22%
VEGFR
22%
CD33
11%
AURKA
11%
AURKB
11%
HDAC
11%
PKC
11%
VEGFR2
11%
ALK
11%
ATR
11%
BCR-ABL1
11%
CDK4
11%
CDK6
11%
EGFR
11%
JAK1
11%
JAK2
11%
MET
11%
PDGFRA
11%
PI3K
11%
ROS1
11%
SMO
11%
SRC
11%
YES1
11%
mTOR
11%
mTORC1
11%
mTORC2
11%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.